In drug testing of pain management patients, it is important that a valid sample is collected in order to determine compliance with appropriate use of prescribed drugs and to identify the use of other non-prescribed drugs or illicit substances. The ease of urine sample adulteration makes it important to address the method of collection.

In this presentation, Dr. Daly discusses testing for adulterants and recent action by CMS concerning billing for urine validity tests.